Test Price
2,800 AED✅ Home Collection Available
GATA3 Gene Hypoparathyroidism, Sensorineural Deafness, and Renal Dysplasia Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين GATA3 لقصور الدريقات والصمم الحسي العصبي وخلل التنسج الكلوي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – Clinical & Operational Confidence
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- Premium Logistics: Hospital-Grade Home Collection with ISO-Certified Cold-Chain Transport (8 AM – 11 PM).
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance to interpret results with a DHA-licensed specialist.
- Insurance: Direct Billing Verification Available – WhatsApp your Emirates ID to +971 54 548 8731.
يُقدم هذا التحليل الجيني الشامل لجين GATA3 بدقة تشخيصية تبلغ 99.9% وفقًا لمعايير هيئة الصحة بدبي لعام 2026. يلتزم مختبرنا بنظام نقل بالغ التبريد معتمد من ISO 9001:2015 ويوفر خدمة السحب المنزلي الفاخر واستشارة ما بعد النتيجة.
Two‑Minute Clinical Overview
The GATA3 gene Next‑Generation Sequencing (NGS) test definitively diagnoses HDR syndrome (hypoparathyroidism, sensorineural deafness, renal dysplasia) by detecting single nucleotide variants, indels, and copy number changes across the entire coding region. يكشف تحليل الجين GATA3 عن الطفرات المسببة لمتلازمة HDR، مما يوفر تشخيصاً جينياً قاطعاً للمرضى وعائلاتهم.
| Feature | Our Test – GATA3 NGS (2800 AED) | Closest Alternative – Targeted GATA3 Panel |
|---|---|---|
| Precision | Full gene sequencing + Sanger validation; detects novel variants & CNVs | Predefined hotspot mutations only; may miss rare pathogenic variants |
| Methodology | Next‑Generation Sequencing (Illumina NovaSeq X Plus) with ACMG 2026 classification | Multiplex PCR/ Sanger limited to known loci |
| Turnaround Time | 3 – 4 Weeks (express possible) | 2 – 4 Weeks (but often requires reflex to full gene test) |
Physician Insight & Safety Protocol
“As clinicians, we see families navigating the uncertainty of multi‑system congenital disorders. This NGS test provides the molecular confirmation that guides precise endocrinology and nephrology surveillance. However, a negative result does not rule out clinical HDR syndrome; always correlate with calcium, PTH, and renal imaging. Your General Physician, Endocrinologist, and Nephrologist must integrate these findings into a holistic care plan.”
— Dr. Prabhakar Reddy, DHA License 61713011
⚠️ Medication Warning: Do not discontinue prescribed calcium, vitamin D, or any other medication without consulting your treating physician. Genetic test results inform long‑term management, not acute therapy.
🚨 Safety Exclusion Criteria & Emergency Red Flags
- Patients with active febrile illness or unmanaged bleeding disorders—home draw may be postponed.
- Individuals unable to provide informed consent (minors require legal guardian consent per UAE CDS Law 2026).
- Seek immediate emergency care if you experience severe tetany, stridor, seizures, or cardiac palpitations while awaiting results—these may indicate acute hypocalcemia and are not related to the blood draw.
Patient FAQ & Clinical Guidance
1. What exactly does this GATA3 gene diagnose?
This NGS assay sequences the entire GATA3 coding region to identify mutations responsible for HDR syndrome—a hereditary disorder combining hypoparathyroidism, sensorineural hearing loss, and renal malformations—enabling definitive molecular diagnosis.
يكشف هذا الفحص المتقدم عن الطفرات في كامل الجين GATA3 المسببة لمتلازمة HDR التي تجمع قصور الدريقات وفقدان السمع الحسي العصبي وعيوب الكلى الخلقية، مما يؤكد التشخيص بدقة.
2. How should I prepare for the blood collection at home?
No fasting is required; a gentle venipuncture obtains 2–4 mL of whole blood in an EDTA tube. The DHA‑licensed phlebotomist will also document your brief clinical history and any family pedigree for accurate interpretation.
لا يشترط الصيام؛ سيسحب فني معتمد من هيئة الصحة بدبي عينة دم وريدية صغيرة ويسجل تاريخك الطبي المختصر ونسب العائلة لضمان تفسير دقيق للنتيجة.
3. When will I receive the report and how is it explained?
Your comprehensive report—including variant classification per ACMG 2026—is dispatched securely within 3–4 weeks. A follow‑up tele‑consultation with our genetic counsellor ensures you fully understand the implications and next steps.
يصدر تقريرك الشامل وفق تصنيف ACMG 2026 خلال 3 إلى 4 أسابيع، ويليه استشارة هاتفية مع مستشار جيني لتوضيح النتائج وخطوات المتابعة اللازمة.
DHA Facility License 9834453 | ISO 9001:2015 (INT/EGQ/2509DA/3139) | UAE PDPL Compliant
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians